SCHEMBL30236246

SCHEMBL30236246

CNc1cc2ncc(-c3cc(NC(=O)c4cc(C(C)(F)F)ccn4)cnc3C)cc2cn1

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ RAF1 P04049 20/20 0.58
▸ BRAF P15056 20/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29272355 1.00 RAF1 (0.58) RAF1BRAF
SCHEMBL30236434 0.95 RAF1 (0.58) RAF1BRAF
SCHEMBL29272231 0.95 RAF1 (0.58) RAF1BRAF
SCHEMBL29272387 0.94 BRAF (0.58) RAF1BRAF
SCHEMBL30237164 0.94 BRAF (0.58) RAF1BRAF
SCHEMBL30236382 0.92 RAF1 (0.50) RAF1BRAF
SCHEMBL29272169 0.92 RAF1 (0.50) RAF1BRAF
SCHEMBL30236523 0.90 RAF1 (0.58) RAF1BRAF
SCHEMBL29272354 0.90 RAF1 (0.58) RAF1BRAF
SCHEMBL29272226 0.89 BRAF (0.60) RAF1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4399210-A1 6-AZA-QUINOLINE DERIVATIVES AND RELATED USES Black Diamond Therapeutics, Inc. (US) 2024-07-17 — — EP disclosed
CN-118159537-A 6-Aza-quinoline derivatives and related uses 黑钻治疗公司 2024-06-07 — — CN disclosed
WO-2023039505-A1 6-AZA-QUINOLINE DERIVATIVES AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2023-03-16 — — WO disclosed
Send feedback